Brand_Name,Sponsor,Therapeutic_Area,TA Notes,TA_subgroup,Indication,Indication_long,Approval_Year,Enrollment,Sex_comparison,Race_comparison,Age_comparison,Race_detail,Female,White,Black,Asian,Hispanic,Other,Age_65_or_older,Age_75_or_older,Age_80_or_older,United_States,FDA_provided_TA
ADDYI,Sprout Pharmaceuticals,Gynecology,,Gynecology,Hypoactive sexual desire disorder,"Treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women ",2015,3099,,,,,100,89,8,1,,2,0,0,0,,No. Dr. Bierer reviewed TA label
ALECENSA,Genentech,Oncology,,NSCLC,NSCLC,For the treatment of metastatic non-small cell lung cancer ,2015,253,,,,,55,74,2,18,,7,14,4,1,,Yes
ARISTADA,Alkermes Inc,Psychiatry,,Schizophrenia,Schizophrenia,Treatment of schizophrenia ,2015,623,,,,,32,47,40,13,,1,0,0,0,,Yes
AVYCAZ-1,Forest Pharmaceuticals,Infectious Disease,,Other Infectious Diseases,Complicated intra-abdominal infection,Treatment of complicated intra-abdominal infection (abbreviated as cIAI) ,2015,203,,,,,26,60,1,27,,12,11,8,4,,No. Dr. Bierer reviewed TA label
AVYCAZ-2,Forest Pharmaceuticals,Infectious Disease,,Urinary tract infection,Urinary tract infection,Treatment of complicated urinary tract infection (abbreviated as cUTI) ,2015,135,,,,,74,60,5,10,,25,17,4,3,,No. Dr. Bierer reviewed TA label
BRIDION,Merck,Anesthesia and Analgesia,Maybe neurology,Anesthesia and Analgesia,Reversal of effects of neuromuscular blocking agents ,For the reversal of the effects of certain neuromuscular blocking agents ,2015,3458,,,,,52,84,3,12,,1,29,1,1,,No. Dr. Bierer reviewed TA label
CHOLBAM-1,Asklepion Pharmaceuticals,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Bile acid synthesis disorders,For treatment of bile acid synthesis disorders due to single enzyme defects ,2015,44,,,,,43,61,11,7,,20,,,,,No. Dr. Bierer reviewed TA label
CHOLBAM-2,Asklepion Pharmaceuticals,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Peroxisomal disorders,"For treatment of peroxisomal disorders, including Zellweger spectrum disorders ",2015,226,,,,,33,83,0,0,,17,,,,,No. Dr. Bierer reviewed TA label
CORLANOR,Amgen,Cardiovascular Diseases,,Heart failure,Heart failure,To reduce hospitalization from worsening heart failure. ,2015,6505,,,,,24,89,1,8,,2,38,11,3,,Yes
COSENTYX,Novartis,Dermatology,,Plaque psoriasis,Plaque psoriasis,Treatment of moderate to severe plaque psoriasis in adults who do not respond well to medication applied directly to the skin ,2015,2044,,,,,30,68,1,22,,9,8,1,1,,No. Dr. Bierer reviewed TA label
COTELLIC,Genentech,Oncology,,Melanoma,Melanoma,Part of combination treatment melanoma ,2015,495,,,,,42,93,,,,7,27,9,3,,Yes
CRESEMBA-1,Astellas Pharma,Infectious Disease,,Other Infectious Diseases,Invasive aspergillosis ,Treatment of invasive aspergillosis ,2015,516,,,,,40,78,1,21,,1,24,5,1,,No. Dr. Bierer reviewed TA label
CRESEMBA-2,Astellas Pharma,Infectious Disease,,Other Infectious Diseases,Invasive mucormycosis,Treatment of invasive mucormycosis ,2015,37,,,,,19,68,11,22,,0,14,8,0,,No. Dr. Bierer reviewed TA label
DAKLINZA,Bristol-Myers-Squibb,Infectious Disease,,Chronic Hepatitis-C,Chronic Hepatitis-C,Treatment of chronic Hepatitis C genotype-3 infection ,2015,226,,,,,41,90,4,5,,1,7,0,0,,No. Dr. Bierer reviewed TA label
DARZALEX,Janssen,Oncology,,Multiple Myeloma,Multiple Myeloma,Treatment of multiple myeloma ,2015,156,,,,,46,76,10,6,,8,45,10,3,,Yes
EMPLICITI,Bristol-Myers-Squibb,Oncology,,Multiple Myeloma,Multiple Myeloma,Treatment of multiple myeloma ,2015,646,,,,,40,84,4,10,,2,57,20,7,,Yes
ENTRESTO,Novartis,Cardiovascular Diseases,,Heart failure,Heart failure,Treatment of heart failure ,2015,8442,,,,,22,66,5,18,,11,49,19,7,,Yes
FARYDAK,Novartis,Oncology,,Multiple Myeloma,Multiple Myeloma,Treatment of multiple myeloma ,2015,193,,,,,48,63,3,33,,1,35,5,0,,Yes
GENVOYA-1,Gilead,Infectious Disease,,HIV-1,HIV-1,Complete regimen for the treatment of HIV-1 in children twelve years of age and older ,2015,23,,,,,48,0,83,17,,0,0,0,0,,No. Dr. Bierer reviewed TA label
GENVOYA-2,Gilead,Infectious Disease,,HIV-1,HIV-1,Complete regimen for the treatment of HIV-1 in adults,2015,3171,,,,,13,61,23,9,,7,3,1,1,,No. Dr. Bierer reviewed TA label
IBRANCE,Pfizer,Oncology,,Breast cancer,Breast cancer,"Treatment of a specific form of advanced breast cancer called ER-positive, HER2- negative (ER+/HER-) breast cancer in women who have gone through menopause (post-menopausal) ",2015,165,,,,,100,90,1,6,,3,46,9,3,,Yes
KANUMA-1,Alexion,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Lysosomal Acid Lipase deficiency,Treatment of Lysosomal Acid Lipase (LAL) deficiency in infants,2015,9,,,,,44,44,11,11,,33,0,0,0,,No. Dr. Bierer reviewed TA label
KANUMA-2,Alexion,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Lysosomal Acid Lipase deficiency,Treatment of Lysosomal Acid Lipase (LAL) deficiency ,2015,66,,,,,50,83,2,5,,11,0,0,0,,No. Dr. Bierer reviewed TA label
KENGREAL,The Medicines Company,Cardiovascular Diseases,,Other Cardiovascular Disease,Prevention of coronary artery blood clot formation in patients undergoing PCI,For prevention of coronary artery blood clot formation in patients undergoing PCI ,2015,11145,,,,,28,94,3,3,,1,48,18,8,,Yes
KYBELLA,Kythera Biopharmaceuticals,Dermatology,,Other Dermatology,Double chin,Treatment for double chin ,2015,1022,,,,,85,87,8,2,,3,1,0,0,,No. Dr. Bierer reviewed TA label
LENVIMA,Eisai,Oncology,,Other oncology,Differentiated thyroid cancer,"Treatment of progressive, differentiated thyroid cancer (DTC) that can no longer be treated with radioactive iodine ",2015,392,,,,,49,79,2,18,,1,40,10,4,,Yes
LONSURF,Taiho Oncology,Oncology,,Other oncology,Colorectal cancer,Treatment of advanced colorectal cancer ,2015,800,,,,,39,58,1,35,,7,44,8,1,,Yes
NATPARA,NPS Pharmaceuticals,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Hypoparathyroidism,For control of hypocalcemia along with calcium and vitamin D in adults with hypoparathyroidism ,2015,124,,,,,79,96,1,2,,2,6,1,1,,No. Dr. Bierer reviewed TA label
NINLARO,Takeda,Oncology,,Multiple Myeloma,Multiple Myeloma,Treatment of multiple myeloma ,2015,722,,,,,43,85,2,9,,5,58,2,1,,Yes
NUCALA,GlaxoSmithKline,Pulmonology and Rheumatology,,Eosinophilic asthma ,Eosinophilic asthma ,For the treatment of a specific type of severe asthma (called eosinophilic phenotype asthma) ,2015,1327,,,,,59,85,3,11,,1,9,10,3,,No. Dr. Bierer reviewed TA label
ODOMZO,Novartis,Oncology,,Melanoma,Melanoma,Treatment of locally advanced basal cell carcinoma ,2015,230,,,,,37,94,1,0,,6,54,34,23,,Yes
ORKAMBI,Vertex,Pulmonology and Rheumatology,,Cystic fibrosis,Cystic fibrosis,Treatment of cystic fibrosis ,2015,1108,,,,,49,99,0,0,,1,0,0,0,,No. Dr. Bierer reviewed TA label
PORTRAZZA,Eli Lilly,Oncology,,NSCLC,NSCLC,For the treatment of metastatic squamous non-small cell lung cancer ,2015,1093,,,,,17,84,1,8,,8,39,4,1,,Yes
PRALUENT,Sanofi,Cardiovascular Diseases,,Hyperlipidemia,Hyperlipidemia,Treatment of certain patients with high cholesterol ,2015,3752,,,,,40,90,4,3,,3,32,6,1,,Yes
PRAXBIND,Boehringer-Ingelheim,Cardiovascular Diseases,,Other Cardiovascular Disease,Reversal of the anticoagulant effects of Pradaxa,Reversal of the anticoagulant effects of Pradaxa during emergency situations or when there is a need to reverse its blood-thinning effects. ,2015,123,,,,,47,85,1,7,,7,90,60,44,,Yes
REPATHA-1,Amgen,Cardiovascular Diseases,,Hyperlipidemia,Hyperlipidemia,Treatment of certain patients with high cholesterol - Patients with Clinical Atherosclerotic Cardiovascular Disease or HeFH,2015,4177,,,,,50,84,5,9,,2,28,3,1,,Yes
REPATHA-2,Amgen,Cardiovascular Diseases,,Hyperlipidemia,Hyperlipidemia,Treatment of certain patients with high cholesterol - Patients with HoFH,2015,49,,,,,49,90,0,4,,6,0,0,0,,Yes
REXULTI-1,Otsuka,Psychiatry,,Schizophrenia,Schizophrenia,Treatment of schizophrenia ,2015,852,,,,,37,63,24,7,,6,1,0,0,,Yes
REXULTI-2,Otsuka,Psychiatry,,Major depressive disorder,Major depressive disorder,Treatment of major depressive disorder ,2015,1054,,,,,69,85,12,1,,2,1,0,0,,Yes
SAVAYSA-1,Daiichi Sankyo,Cardiovascular Diseases,,Other Cardiovascular Disease,Venous thromboembolism,Reduction of risk of venous thromboembolism (VTE) in patients with previous VTE ,2015,8292,,,,,43,70,4,21,,5,33,13,6,,Yes
SAVAYSA-2,Daiichi Sankyo,Cardiovascular Diseases,,Other Cardiovascular Disease,Prevention of stroke,Prevention of stroke in patients with atrial fibrillation ,2015,21026,,,,,38,81,1,14,,4,74,40,17,,Yes
STRENSIQ-1,Alexion,Endocrinology and Metabolism,,Hypophosphatasia,Hypophosphatasia,"Treatment of perinatal, infantile -onset hypophosphatasia (HPP) ",2015,79,,,,,52,81,0,9,,10,0,0,0,,No. Dr. Bierer reviewed TA label
STRENSIQ-2,Alexion,Endocrinology and Metabolism,,Hypophosphatasia,Hypophosphatasia,Treatment of juvenile-onset hypophosphatasia (HPP) ,2015,20,,,,,50,95,0,0,,5,0,0,0,,No. Dr. Bierer reviewed TA label
TAGRISSO,AstraZeneca,Oncology,,NSCLC,NSCLC,Treatment of patients with advanced nonsmall cell lung cancer (NSCLC) ,2015,411,,,,,68,36,1,60,,3,45,13,4,,Yes
TRESIBA-1,Novo Nordisk,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Type 1 diabetes mellitus,To improve glucose control in adults with type 1 diabetes mellitus ,2015,1577,,,,,44,80,1,16,,2,7,1,1,,No. Dr. Bierer reviewed TA label
TRESIBA-2,Novo Nordisk,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Type 2 diabetes mellitus,To improve glucose control in adults with type 2 diabetes mellitus ,2015,4048,,,,,44,70,7,21,,2,24,3,1,,No. Dr. Bierer reviewed TA label
UNITUXIN,United Therapeutics Corporation,Oncology,,Other oncology,Neuroblastoma,Treatment of children with high-risk neuroblastoma ,2015,226,,,,,40,82,7,3,,8,,,,,Yes
UPTRAVI,Actelion Therapeutics,Cardiovascular Diseases,,Hypertension,Hypertension,For the treatment of adults with pulmonary artery hypertension ,2015,1156,,,,,80,75,2,21,,2,18,1,1,,Yes
VARUBI,Tesaro,Anesthesia and Analgesia,,Anesthesia and Analgesia,Chemotherapy induced nausea and vomiting ,To prevent delayed phase chemotherapy induced nausea and vomiting ,2015,2595,,,,,60,75,2,14,,9,26,5,1,,No. Dr. Bierer reviewed TA label
VELTASSA,Relypsa,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Hyperkalemia,Treatment of hyperkalemia ,2015,715,,,,,39,99,1,1,,1,61,21,4,,No. Dr. Bierer reviewed TA label
VIBERZI,Forest Pharmaceuticals,Gastroenterology,,Gastroenterology,Irritable bowel syndrome,Treatment of irritable bowel syndrome with diarrhea ,2015,2425,,,,,66,86,12,1,,2,10,6,1,,No. Dr. Bierer reviewed TA label
VRAYLAR-1,Forest Laboratories,Psychiatry,,Schizophrenia,Schizophrenia,Treatment of schizophrenia ,2015,1065,,,,,28,43,34,17,,6,1,0,0,,Yes
VRAYLAR-2,Forest Laboratories,Psychiatry,,Bipolar disorder,Bipolar disorder,Treatment of bipolar disorder ,2015,1754,,,,,41,49,25,24,,2,1,0,0,,Yes
XURIDEN,Wellstat Therapeutics Corporation,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Hereditary orotic aciduria,Treatment of patients with hereditary orotic aciduria ,2015,4,,,,,25,100,0,0,,0,,,,,No. Dr. Bierer reviewed TA label
YONDELIS,Janssen,Oncology,,Other oncology,Advanced tissue sarcomas,Treatment of certain types of advances tissue sarcoma ,2015,518,,,,,70,76,12,4,,8,22,3,1,,Yes
ZURAMPIC,AstraZeneca,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Gout,For lowering uric acid levels in the blood of adult patients with gout ,2015,1027,,,,,4,78,12,6,,5,13,3,1,,No. Dr. Bierer reviewed TA label
ADLYXIN-1,Sanofi,Endocrinology and Metabolism,,Type 2 diabetes,Type 2 diabetes,Treatment of type-2 diabetes mellitus ,2016,4508,,,,,52,64,3,32,,2,19,,,,No. Dr. Bierer reviewed TA label
ADLYXIN-2,Sanofi,Endocrinology and Metabolism,,Type 2 diabetes,Type 2 diabetes,Treatment of type-2 diabetes mellitus who recently suffered a heart attack,2016,6068,,,,,31,75,4,13,,8,34,,,,No. Dr. Bierer reviewed TA label
ANTHIM,Elusys Therapeutics,Infectious Disease,,Other Infectious Diseases,Inhalational anthrax,For the treatment of inhalational anthrax ,2016,370,,,,,46,69,28,1,,2,9,,,,No. Dr. Bierer reviewed TA label
AXUMIN,Blue Earth Diagnostics,Oncology,,Prostate cancer,Prostate cancer,Detection of prostate cancer recurrence ,2016,596,,,,,0,31,4,1,,64,66,,,,No. Dr. Bierer reviewed TA label
BRIVIACT,UCB,Neurology,,Seizures,Seizures,Treatment of partial-onset seizures ,2016,1558,,,,,49,74,3,12,,11,2,,,,No. Dr. Bierer reviewed TA label
CINQUAIR,Teva Pharmaceuticals,Pulmonology and Rheumatology,,Eosinophilic asthma ,Eosinophilic asthma ,For the treatment of a specific type of severe asthma (called eosinophilic phenotype asthma) ,2016,1758,,,,,62,73,12,8,,8,6,,,,No. Dr. Bierer reviewed TA label
DEFITELIO,Jazz Pharmaceuticals,Oncology,,Other oncology,Hepatic veno-occlusive disease,Treatment of hepatic veno-occlusive disease (VOD) ,2016,528,,,,,45,71,6,4,,19,0,,,,No. Dr. Bierer reviewed TA label
EPCLUSA,Gilead,Infectious Disease,,Chronic Hepatitis-C,Chronic Hepatitis-C,"Treatment of chronic Hepatitis C virus genotypes-1,2,3,4,5_or_6_infection ",2016,1825,,,,,38,85,6,7,,2,11,,,,No. Dr. Bierer reviewed TA label
EUCRISA,Anacor Pharmaceuticals,Dermatology,,Other Dermatology,Eczema (atopic dermatitis),To treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older ,2016,1522,,,,,56,61,28,5,,6,0,,,,No. Dr. Bierer reviewed TA label
EXONDYS_51-1,Serepta,Neurology,,Muscular dystrophy,Muscular dystrophy,Treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon_51 skipping ,2016,12,,,,,0,92,0,8,,0,0,,,,No. Dr. Bierer reviewed TA label
EXONDYS_51-2,Serepta,Neurology,,Muscular dystrophy,Muscular dystrophy,Treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon_51 skipping ,2016,13,,,,,0,100,0,0,,0,0,,,,No. Dr. Bierer reviewed TA label
LARTRUVO,Eli Lilly,Oncology,,Other oncology,Soft tissue sarcoma,Treatment of soft tissue sarcoma ,2016,133,,,,,56,86,8,3,,2,32,,,,No. Dr. Bierer reviewed TA label
NETSPOT,Advanced Accelerator Applications,Oncology,,Other oncology,Neuroendocrine tumors,For detection of a specific type of tumors called somatostatin receptor positive neuro-endocrine tumors (NETs) ,2016,265,,,,,52,,,,,100,,,,,No. Dr. Bierer reviewed TA label
NUPLAZID,Acadia Pharmaceuticals,Neurology,(or Psychiatry),Parkinson's,Parkinson's,Treatment of hallucinations and delusions in patients with Parkinsons disease ,2016,433,,,,,36,91,1,5,,3,82,,,,No. Dr. Bierer reviewed TA label
OCALIVA,Intercept Pharmaceuticals,Gastroenterology,,Gastroenterology,Primary biliary cholangitis,Treatment of primary biliary cholangitis in adults ,2016,216,,,,,91,94,1,1,,3,19,,,,No. Dr. Bierer reviewed TA label
RUBRACA,Clovis Oncology,Oncology,,Other oncology,Ovarian cancer,Treatment of women with certain type of advanced ovarian cancer ,2016,377,,,,,100,80,2,6,,12,42,,,,No. Dr. Bierer reviewed TA label
SPINRAZA,Biogen,Neurology,,Other Neurology,Spinal muscular atrophy,Spinal muscular atrophy (SMA) ,2016,121,,,,,55,86,2,6,,6,0,,,,No. Dr. Bierer reviewed TA label
TALTZ,Eli Lilly,Dermatology,,Plaque psoriasis,Plaque psoriasis,Treatment of moderate to severe plaque psoriasis in adults ,2016,1958,,,,,32,93,2,4,,1,7,,,,No. Dr. Bierer reviewed TA label
TECENTRIQ,Genentech,Oncology,,Bladder cancer,Bladder cancer,Treatment of a type of bladder cancer called urothelial carcinoma ,2016,310,,,,,78,91,2,2,,5,59,,,,No. Dr. Bierer reviewed TA label
VENCLEXTA,AbbVie / Genentech,Oncology,,Leukemia,Leukemia,Treatment of chronic lymphocytic leukemia (CLL) ,2016,240,,,,,31,94,3,1,,3,58,,,,No. Dr. Bierer reviewed TA label
XIIDRA,Shire,Ophthalmology,,Ophthalmology,Dry eye disease,Treatment of the signs and symptoms of dry eye disease ,2016,2133,,,,,76,85,9,4,,2,37,,,,No. Dr. Bierer reviewed TA label
ZEPATIER,Merck,Infectious Disease,,Chronic Hepatitis-C,Chronic Hepatitis-C,Treatment of chronic Hepatis C genotypes-1-or-4 infection ,2016,2704,,,,,39,75,15,9,,1,11,,,,No. Dr. Bierer reviewed TA label
ZINBRYTA,Biogen,Neurology,,Multiple Sclerosis,Multiple Sclerosis,Treatment of relapsing forms of multiple sclerosis (MS) ,2016,2253,,,,,67,91,1,3,,5,0,,,,No. Dr. Bierer reviewed TA label
ZINPLAVA,Merck,Infectious Disease,,Other Infectious Diseases,Clostridium difficile infection,Decreasing the risk of Clostridium difficile infection recurrence ,2016,1567,,,,,57,85,5,8,,2,62,,,,No. Dr. Bierer reviewed TA label
ALIQOPA,Bayer,Oncology,,Lymphoma,Lymphoma,Treatment of relapsed follicular lymphoma,2017,168,,,,,54,83,0,9,6,,48,,,13,Yes
ALUNBRIG,Ariad Pharmaceuticals,Oncology,,NSCLC,NSCLC,Treatment of metastatic non-small cell lung cancer,2017,222,,,,,57,67,1,31,6,,23,,,,Yes
AUSTEDO,Teva Pharmaceuticals,Neurology,,Other Neurology,Huntington's disease,Treatment of chorea associated with Huntington's disease,2017,90,,,,,44,92,6,0,0,,19,,,93,Yes
BAVENCIO,EMD Serono,Oncology,,Melanoma,Melanoma,Treatment of metastatic Merkel cell carcinoma,2017,88,,,,,26,92,0,3,6,,75,,,58,Yes
BAXDELA,Melinta Therapeutics,Infectious Disease,,Other Infectious Diseases,Acute bacterial skin and skin structure infections,Treatment of actue bacteria skin and skin structure infection,2017,1510,,,,,37,86,5,0,28,,14,,,52,Yes
BENZNIDAZOLE,Exeltis,Infectious Disease,,Other Infectious Diseases,Chagas disease,Treatment of Chagas disease,2017,235,,,,,46,,,,,,0,,,0,Yes
BESPONSA,Pfizer,Oncology,,Leukemia,Leukemia,Treatment of B-cell acute lymphocytic leukemia,2017,326,,,,,41,71,2,17,,,37,,,47,Yes
BEVYXXA,Portola Pharmaceuticals,Hematology,,Other Hematology,Venous thromboembolism,Prevention of venous thromboembolism,2017,7513,,,,,54,93,2,1,11,,90,,,7,No. Dr. Bierer reviewed TA label
BRINEURA,BioMarin Pharmaceutical,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Batten disease,Treatment of Batten disease,2017,24,,,,,63,96,0,4,4,,0,,,13,No. Dr. Bierer reviewed TA label
CALQUENCE,AstraZeneca,Oncology,,Lymphoma,Lymphoma,Treatment of mantle cell lymphoma,2017,124,,,,,20,74,3,0,3,,65,,,36,Yes
DUPIXENT,Regeneron,Dermatology,,Other Dermatology,Atopic dermatitis,Treatment of atopic dermatitis,2017,1338,,,,,42,67,6,24,4,,4,,,34,No. Dr. Bierer reviewed TA label
EMFLAZA,Marathon Pharmaceuticals,Neurology,,Muscular dystrophy,Muscular dystrophy,Treatment of Duchenne musuclar dystrophy,2017,196,,,,,0,94,0,1,,,0,,,,Yes
FASENRA,AstraZeneca,Pulmonology and Rheumatology,,Eosinophilic asthma ,Eosinophilic asthma,Treatment of eosinophilic asthma,2017,1817,,,,,63,80,3,12,20,,13,,,15,No. Dr. Bierer reviewed TA label
GIAPREZA,La Jolla Pharmaceutical Company,Infectious Disease,(really ICU Medicine),Other Infectious Diseases,To increase blood pressure in septic shock,To increase blood pressure in septic or other distributive shock,2017,321,,,,,39,80,10,4,5,,48,,,74,No. Dr. Bierer reviewed TA label
HEMLIBRA,Genentech,Hematology,,Other Hematology,Hemophilia A,To prevent or reduce bleeding in patients with hemophilia A,2017,189,,,,,0,56,11,26,12,,3,,,28,No. Dr. Bierer reviewed TA label
IDHIFA,Celgene,Oncology,,Leukemia,Leukemia,Treatment of relapsed acute myelogenous leukemia,2017,214,,,,,49,77,6,1,9,,60,,,83,Yes
IMFINZI,AstraZeneca,Oncology,,Bladder cancer,Bladder cancer,Treatment of urothelial carcinoma,2017,182,,,,,28,64,3,20,,,62,,,49,Yes
INGREZZA,Neurocrine Biosciences,Neurology,,Other Neurology,Tardive dyskinesia,Treatment of tardive dyskinesia,2017,445,,,,,42,57,39,1,28,,18,,,100,Yes
KEVZARA,Sanofi,Pulmonology and Rheumatology,,Rheumatoid arthritis ,Rheumatoid arthritis ,Treatment of rheumatoid arthritis,2017,1740,,,,,82,81,3,6,39,,13,,,14,No. Dr. Bierer reviewed TA label
KISQALI,Novartis,Oncology,,Breast cancer,Breast cancer,Treatment of HR-positive HER2-negative breast cancer,2017,668,,,,,100,82,3,8,10,,44,,,32,Yes
MACRILEN,Aeterna Zentaris,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Adult growth hormone deficiency,Diagnosis of adult growth hormone deficiency,2017,154,,,,,42,86,2,3,,,2,,,24,Yes
MAVYRET,AbbVie,Infectious Disease,,Chronic Hepatitis-C,Chronic Hepatitis-C,"Treatment of chronic hepatitis C genotypes 1,2,3,4,5 or 6",2017,2369,,,,,44,80,6,12,9,,14,,,32,Yes
MEPSEVII,Ultragenyx Pharmaceuticals,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Mucopolysacchairdosis VII,Treatment of mucopolysacchairdosis VII,2017,12,,,,,67,75,0,0,50,,0,,,100,No. Dr. Bierer reviewed TA label
NERLYNX,Puma Biotechnology,Oncology,,Breast cancer,Breast cancer,Treatment of HER2 positive breast cancer,2017,2840,,,,,100,81,3,13,2,,12,,,32,Yes
OCREVUS,Genentech,Neurology,,Multiple Sclerosis,Multiple Sclerosis,Treatment of multiple sclerosis,2017,2388,,,,,61,92,4,0,11,,0,,,26,Yes
OZEMPIC,Novo Nordisk,Endocrinology and Metabolism,,Type 2 diabetes,Type 2 diabetes,Treatment of type 2 diabetes mellitus,2017,7384,,,,,42,70,6,22,16,,34,,,28,Yes
PARSABIV,Amgen,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Secondary hyperparathyroidism,Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on hemodialysis,2017,226,,,,,40,66,28,3,13,,35,,,52,Yes
PREVYMIS,Merck,Infectious Disease,,Other Infectious Diseases,Prevention of cytomeglaovirus infection,Prevention of cytomeglaovirus infection in allogenic hematopoietic stem cell transplant,2017,565,,,,,42,82,2,10,7,,16,,,36,Yes
RADICAVA,Mitsubishi Tanabe Pharma Corporation,Neurology,,Other Neurology,Amyotrophic lateral sclerosis,Treatment of amyotrophic lateral sclerosis,2017,368,,,,,39,0,0,100,0,,30,,,0,Yes
RHOPRESSA,Aerie Pharmaceuticals,Ophthalmology,,Ophthalmology,Open angle glaucoma,Treatment of open angle glaucoma,2017,1875,,,,,62,73,25,2,19,,54,,,100,No. Dr. Bierer reviewed TA label
RYDAPT,Novartis,Oncology,,Leukemia,Leukemia,Treatment of acute myelpgenous leukemia,2017,717,,,,,56,38,2,2,2,,0,,,33,Yes
RYDAPT,Novartis,Oncology,,Other oncology,Systemic mastocytosis,Treatment of systemic mastocytosis,2017,142,,,,,36,93,1,0,3,,45,,,41,Yes
SILIQ,Valeant Pharmaceuticals,Dermatology,,Plaque psoriasis,Plaque psoriasis,Treatment of plaque psoriasis,2017,2915,,,,,31,91,3,3,,,6,,,22,No. Dr. Bierer reviewed TA label
SOLOSEC,Symbiomix Therapeutics,Infectious Disease,,Other Infectious Diseases,Bacterial vaginosis,Treatment of bacterial vaginosis,2017,333,,,,,100,46,50,1,15,,0,,,100,Yes
STEGLATRO,Merck,Endocrinology and Metabolism,,Type 2 diabetes,Type 2 diabetes,Treatment of type 2 diabetes mellitus,2017,4859,,,,,48,77,5,13,24,,26,,,28,Yes
SYMPROIC,Shionogi,Gastroenterology,,Gastroenterology,Opioid-induced constipation,Treatment of opioid-induced constipation,2017,2336,,,,,62,80,18,1,8,,15,,,85,No. Dr. Bierer reviewed TA label
TREMFYA,Janssen,Dermatology,,Plaque psoriasis,Plaque psoriasis,Treatment of plaque psoriasis,2017,1829,,,,,29,82,2,14,6,,5,,,20,No. Dr. Bierer reviewed TA label
TRULANCE,Synergy Pharmaceuticals,Gastroenterology,,Gastroenterology,Chronic idiopathic constipation,Treatment of chronic idiopathic constipation,2017,1733,,,,,79,72,23,3,41,,11,,,98,No. Dr. Bierer reviewed TA label
TYMLOS,Radius Health,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Postmenopausal osteoporosis,Treatment of postmenopausal osteoporosis,2017,1645,,,,,100,80,3,16,24,,81,,,2,Yes
VABOMERE,The Medicines Company,Infectious Disease,,Urinary tract infection,Urinary tract infection,Treatment of complicated urninary tract infection,2017,545,,,,,66,93,1,2,8,,35,,,3,Yes
VERZENIO,Eli Lilly,Oncology,,Breast cancer,Breast cancer,Treatment of HR-positive HER2-negative breast cancer,2017,801,,,,,100,61,2,27,12,,36,,,19,Yes
VOSEVI,Gilead,Infectious Disease,,Chronic Hepatitis-C,Chronic Hepatitis-C,"Treatment of hepatitis C genotypes 1,2,3,4,5 or 6",2017,748,,,,,23,84,12,2,7,,16,,,57,Yes
VYZULTA,Bausch & Lomb,Ophthalmology,,Ophthalmology,Glaucoma,Treatment of Glaucoma,2017,840,,,,,58,74,24,1,12,,52,,,91,No. Dr. Bierer reviewed TA label
XADAGO,Newron Pharmaceuticals,Neurology,,Parkinson's,Parkinson's,Treatement of Parkinson's disease,2017,1218,,,,,33,41,1,59,2,,38,,,8,Yes
XEPI,Medimetriks Pharmaceuticals,Infectious Disease,,Other Infectious Diseases,Inpetigo,Treatment of inpetigo,2017,723,,,,,44,53,34,4,17,,3,,,23,Yes
XERMELO,"Lexicon Pharmaceuticals, Inc.",Gastroenterology,(or Oncology),Gastroenterology,Carcinoid syndrome diarrhea,Treatment of carcinoid syndrome diarrhea,2017,90,,,,,50,90,1,0,0,,49,,,32,No. Dr. Bierer reviewed TA label
ZEJULA,Tesaro,Oncology,,Other oncology,Ovarian cancer,Treatment of ovarian cancer,2017,553,,,,,100,87,1,3,3,,35,,,70,Yes
AEMCOLO,Conventus BioMedical Solutions,Infectious Disease,,Other Infectious Diseases,Travelers diarrhea,Treatment of travelers diarrhea in adults ,2018,1099,yes,no,no,no - white majority,50,83,1,14,3,,9,,,0,Yes
AIMOVIG,Amgen,Neurology,,Migraine,Migraine,Preventive treatment of migraine in adults ,2018,2184,yes,no,yes,no - white majority,85,15,7,1,7,,0,,,49,Yes
AJOVY,Teva Pharmaceuticals,Neurology,,Migraine,Migraine,Preventive treatment of migraine in adults ,2018,1986,yes,no,no,no - white majority,87,80,9,10,10,,2,,,73,Yes
AKYNZEO,HELSINN Healthcare,Anesthesia and Analgesia,?Oncology,Anesthesia and Analgesia,Chemotherapy induced nausea and vomiting ,Prevention of the nausea and vomiting in adults receiving chemotherapy ,2018,844,yes,no,yes,no - white majority,40,100,1,1,,,32,,,1,No. Dr. Bierer reviewed TA label
ANNOVERA,"The Population Council, Inc",Gynecology,,Gynecology,Pregnancy prevention,Pregnancy prevention in women ,2018,2308,n/a - women,yes,no,yes,100,70,14,4,30,,0,,,67,No. Dr. Bierer reviewed TA label
ASPARLAS,Baxalta,Oncology,,Leukemia,Leukemia,Treatment of acute lymphoblastic leukemia (ALL) in children and young adults ,2018,237,yes,no,yes,no - white majority,38,70,5,4,17,,0,,,62,Yes
BIKTARVY,Gilead,Infectious Disease,,HIV-1,HIV-1,Treatment of human immunodeficiency virus-1 (HIV-1) infection in adults ,2018,2414,yes,yes,no,yes,13,63,29,3,21,,2,,,65,Yes
BRAFTOVI,Array Biopharma,Oncology,,Melanoma,Melanoma,Treatment of melanoma (a type of skin cancer) when used with another drug binimetinib ,2018,383,yes,no,yes,no - white majority,41,91,0,3,9,,29,,,9,Yes
COPIKTRA,Verastem,Oncology,,Leukemia,Leukemia,"Treatment of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma (FL) ",2018,442,yes,no,yes,no - white majority,35,92,3,1,11,,61,,,30,Yes
CRYSVITA,Ultragenyx Pharmaceutical,Endocrinology and Metabolism,,Hypophosphatasia,Hypophosphatasia,Treatment of X-linked hypophosphatemia ,2018,199,yes,no,yes,no - white majority,60,83,3,11,8,,1,,,59,No. Dr. Bierer reviewed TA label
DAURISMO,Pfizer,Oncology,,Leukemia,Leukemia,Treatment of newly diagnosed acute myeloid leukemia (ALL) in those who cannot tolerate induction chemotherapy. ,2018,125,yes,no,yes,no - white majority,28,98,1,2,,,98,,,23,Yes
DIACOMIT,Biocodex,Neurology,,Other Neurology,Dravet syndrome,Treatment of seizures associated with Dravet syndrome in patients two years and older taking clobazam ,2018,64,yes,no,no,not collected,53,,,,,,0,,,0,Yes
DOPTELET,Dova Pharmaceuticals,Hematology,,Other Hematology,Low platelet count ,Treatment of adults with low platelet count ,2018,435,yes,yes,yes,yes,35,60,3,33,18,,25,,,19,No. Dr. Bierer reviewed TA label
ELZONRIS,Stemline Therapeutics,Oncology,,Other oncology,Blastic plasmacytoid dendritic cell neoplasm,Treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and children ,2018,94,yes,no,yes,no - white majority,23,90,4,3,10,,56,,,100,Yes
EMGALITY,Eli Lilly,Neurology,,Migraine,Migraine,Preventive treatment of migraine in adults ,2018,2156,yes,no,no,no - white majority,85,77,8,6,21,,1,,,62,Yes
EPIDIOLEX,Greenwich Research,Neurology,,Seizures,Seizures,Treatment of seizures in two rare and severe forms of epilepsy. ,2018,550,yes,no,yes,no - white majority,46,86,4,2,2,,0,,,75,Yes
ERLEADA,Janssen,Oncology,,Prostate cancer,Prostate cancer,Treatment of prostate cancer that has not spread to other parts of the body (non-metastatic) ,2018,1207,n/a - men,yes,yes,yes,0,66,6,12,1,,88,,,28,Yes
FIRDAPSE,Catalyst Pharmaceuticals,Neurology,,Other Neurology,Lambert-Eaton myasthenic syndrome,Treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults ,2018,64,no,no,no,no - white majority,61,89,1,1,13,,20,,,61,Yes
GALAFOLD,Amicus Therapeutics,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Fabry disease,Treatment of Fabry disease in adults ,2018,67,yes,no,no,no - white majority,64,97,0,0,6,,1,,,30,No. Dr. Bierer reviewed TA label
GAMIFANT,Novimmune,Hematology,,Other Hematology,Primary hemophagocytic lymphohistiocytosis ,Treatment of patients with primary hemophagocytic lymphohistiocytosis ,2018,34,no,no,no,no - white majority,53,65,9,15,,,0,,,24,No. Dr. Bierer reviewed TA label
ILUMYA,Merck,Dermatology,,Plaque psoriasis,Plaque psoriasis,Treatment of moderate to severe plaque psoriasis ,2018,1060,yes,no,no,no - white majority,29,80,3,14,9,,9,,,33,No. Dr. Bierer reviewed TA label
KRINTAFEL,GlaxoSmithKline,Infectious Disease,,Other Infectious Diseases,Malaria,Prevention of malaria relapse caused by the parasite Plasmodium vivax ,2018,522,yes,no,no,no - non-white majority,25,2,11,19,70,,2,,,0,Yes
LIBTAYO,Regeneron,Oncology,,Melanoma,Melanoma,Treatment of advanced skin cancer (squamous cell carcinoma) ,2018,163,yes,no,yes,no - white majority,15,96,1,1,3,,72,,,62,Yes
LOKELMA,AstraZeneca,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Hyperkalemia,Treatment of hyperkalemia in adults ,2018,1011,yes,yes,yes,yes,41,85,12,2,33,,57,,,90,No. Dr. Bierer reviewed TA label
LORBRENA,Pfizer,Oncology,,NSCLC,NSCLC,Treatment of specific type of lung cancer ,2018,295,yes,no,yes,no - white & asian majority,58,49,1,37,,,18,,,34,Yes
LUCEMYRA,US WorldMeds,Psychiatry,or Anesthesia and Analgesia,Opioid withdrawal,Opioid withdrawal,Treatment of symptoms associated with opioid withdrawal during abrupt opioid discontinuation. ,2018,866,yes,no,yes,no - white majority,28,67,22,1,17,,1,,,100,No. Dr. Bierer reviewed TA label
LUMOXITI,AstraZeneca,Oncology,,Leukemia,Leukemia,Treatment of hairy cell leukemia in adults ,2018,80,yes,no,yes,no - white majority,21,90,1,1,6,,39,,,44,Yes
LUTATHERA,Advanced Accelerator Applications,Oncology,,Other oncology,Neuroendocrine tumors,Treatment of somatostatin receptor-positive gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) ,2018,229,yes,no,yes,no - white majority,49,82,4,1,3,,49,,,58,Yes
MEKTOVI,Array Biopharma,Oncology,,Melanoma,Melanoma,Treatment of melanoma (a type of skin cancer) when used with another drug encorafenib ,2018,383,yes,no,yes,no - white majority,41,91,0,3,9,,29,,,9,Yes
MOTEGRITY,Shire,Gastroenterology,,Gastroenterology,Chronic idiopathic constipation,Treatment of chronic idiopathic constipation (CIC) in adults ,2018,2484,yes,no,yes,no - white & asian majority,76,76,3,19,,,15,,,3,No. Dr. Bierer reviewed TA label
MOXIDECTIN,Medicines Development for Global Health,Infectious Disease,,Other Infectious Diseases,Onchocerciasis,Treatment of onchocerciasis in patients twelve years of age and older ,2018,1472,yes,no,yes,no - black majority,36,0,100,0,0,,9,,,0,Yes
MULPLETA,Shionogi,Hematology,,Other Hematology,Low platelet count ,Treatment of adults with low platelet count ,2018,341,yes,yes,yes,yes,41,50,1,47,8,,37,,,9,No. Dr. Bierer reviewed TA label
NUZYRA-1,Paratek Pharmaceuticals,Infectious Disease,,Other Infectious Diseases,Acute bacterial skin and skin structure infections,Treatment of bacterial skin infections known as acute bacterial skin and skin structure infections (ABSSSI) caused by certain bacteria ,2018,1390,Unknown,no,Unknown,no,42,92,4,1,35,,7,,,83,Yes
NUZYRA-2,Paratek Pharmaceuticals,Infectious Disease,,Other Infectious Diseases,Community-acquired bacterial pneumonia,Treatment of community-acquired bacterial pneumonia (CABP) ,2018,774,yes,no,yes,no - white majority,45,92,2,5,3,,42,,,1,No. Dr. Bierer reviewed TA label
OLUMIANT,Eli Lilly,Pulmonology and Rheumatology,,Rheumatoid arthritis ,Rheumatoid arthritis,Treatment of adult patients with rheumatoid arthritis (RA) whose disease was not well controlled using RA medications called Tumor Necrosis Factor (TNF) antagonists ,2018,2456,yes,yes,yes,yes,80,67,3,25,25,,18,,,22,No. Dr. Bierer reviewed TA label
OMEGAVEN,Fresenius Kabi,Endocrinology and Metabolism,(could be GI?),Other Endocrinology and Metabolism,Parenteral nutrition-associated cholestasis,Treatment of parenteral nutrition-associated cholestasis (PNAC) ,2018,189,no,no,no,no,42,63,12,4,20,,0,,,100,No. Dr. Bierer reviewed TA label
ONPATTRO,Alnylam Pharmaceuticals,Neurology,,Other Neurology,Transthyretin-mediated amyloidosis ,Treatment of nerve damage in adult patients with hereditary tranthyretin-mediated amyloidosis ,2018,225,yes,no,yes,no - white majority,26,73,2,23,12,,42,,,19,Yes
ORILISSA,Abbvie,Gynecology,,Gynecology,Endometriosis ,Treatment of moderate to severe pain associated with endometriosis ,2018,1686,n/a - women,no,yes,no - white majority,100,88,9,1,15,,0,,,75,No. Dr. Bierer reviewed TA label
OXERVATE,Dompé farmaceutici,Ophthalmology,,Ophthalmology,Neurotrophic keratitis ,Treatment of neurotrophic keratitis ,2018,151,yes,no,yes,no - white majority,62,90,3,,10,,47,,,31,No. Dr. Bierer reviewed TA label
PALYNZIQ,BioMarin Pharmaceutical,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Phenylketonuria,Lowering the blood levels of phenylalanine in adults with phenylketonuria (PKU) ,2018,285,yes,no,no,no - white majority,50,98,1,0,3,,0,,,100,No. Dr. Bierer reviewed TA label
PIFELTRO,Merck,Infectious Disease,,HIV-1,HIV-1,Treatment of HIV-1 infection in adults ,2018,1494,yes,yes,no,yes,16,61,21,9,28,,1,,,30,Yes
POTELIGEO,Kyowa Kirin,Oncology,,Lymphoma,Lymphoma,Treatment of adults with mycosis fungoides or Sezary syndrome ,2018,372,yes,no,yes,no - white majority,42,70,10,5,4,,50,,,54,Yes
REVCOVI,Lediant Biosciences,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Adenosine deaminase severe combined immune deficiency,Treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID). ,2018,10,no,no,no,no,40,30,10,40,30,,0,,,60,No. Dr. Bierer reviewed TA label
SEYSARA,Allergan,Dermatology,,Acne vulgaris,Acne vulgaris,Treatment of certain types of acne vulgaris in patients nine years and older ,2018,2133,yes,yes,yes,yes,58,77,16,3,27,,0,,,100,No. Dr. Bierer reviewed TA label
SYMDEKO,Vertex,Pulmonology and Rheumatology,,Cystic fibrosis,Cystic fibrosis,Treatment of cystic fibrosis ,2018,916,yes,no,yes,no - white majority,50,97,1,1,3,,0,,,0,No. Dr. Bierer reviewed TA label
TAKHZYRO,Dyax Corp.,Dermatology,"Really unclear. Could be metabolism? Really ""allergy""",Other Dermatology,Hereditary angioedema,Prevention of attacks of hereditary angioedema in people twelve years and older ,2018,125,yes,no,no,no - white majority,70,90,8,2,4,,4,,,7,No. Dr. Bierer reviewed TA label
TALZENNA,Pfizer,Oncology,,Breast cancer,Breast cancer,Treatment of adults with a specific form of breast cancer ,2018,431,n/a - women,no,yes,no - white majority,98,70,3,11,11,,9,,,36,Yes
TAVALISSE,Rigel Pharmaceuticals,Hematology,,Other Hematology,Chronic immune thrombocytopenia,Treatment of adults with low platelet count due to chronic immune thrombocytopenia (ITP) ,2018,150,yes,no,yes,no - white majority,61,93,3,3,3,,26,,,13,No. Dr. Bierer reviewed TA label
TEGSEDI,Ionis Pharmaceuticals,Neurology,,Other Neurology,Transthyretin-mediated amyloidosis ,Treatment of nerve damage in adult patients with hereditary transthyretin-mediated amyloidosis ,2018,172,yes,no,yes,no - white majority,31,93,2,2,14,,43,,,48,Yes
TIBSOVO,Agios Pharmaceuticals,Oncology,,Leukemia,Leukemia,Treatment of adults with acute myeloid leukemia (AML) that have a mutation in a gene called IDH1 and whose disease has come back or has not improved after previous treatment(s) ,2018,179,yes,no,yes,no - white majority,50,63,6,3,5,,37,,,83,Yes
TPOXX,SIGA Technologies,Infectious Disease,,Other Infectious Diseases,Smallpox disease,Treatment of smallpox disease ,2018,449,yes,yes,no,yes,59,69,28,1,11,,10,,,100,Yes
TROGARZO,Thera,Infectious Disease,,HIV-1,HIV-1,Treatment of human immunodeficiency virus-1 (HIV-1) infection in adults. ,2018,40,no,no,no,no,15,55,33,10,25,,5,,,90,Yes
ULTOMIRIS,Alexion,Hematology,,Other Hematology,Paroxysmal nocturnal hemoglobinuria,Treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH) ,2018,441,yes,no,yes,no - white & asian majority,47,47,3,39,6,,14,,,4,No. Dr. Bierer reviewed TA label
VITRAKVI,Bayer,Oncology,,Other oncology,Metastatic solid tumors,Treatment of solid tumors which are metastatic and beyond surgical resection or do not have any other therapeutic options ,2018,176,yes,no,no,no - white majority,48,72,8,3,11,,21,,,88,Yes
VIZIMPRO,Pfizer,Oncology,,NSCLC,NSCLC,Treatment of advanced non-small cell lung cancer ,2018,452,yes,no,yes,no - asian majority,60,23,1,77,0,,40,,,0,Yes
XERAVA,"Tetraphase Pharmaceuticals, Inc.",Infectious Disease,,Other Infectious Diseases,Intra-abdominal infections,Treatment of complicated intra-abdominal infections caused by bacteria ,2018,1037,yes,no,yes,no - white majority,43,98,1,1,2,,30,,,5,Yes
XOFLUZA,Genentech,Infectious Disease,,Other Infectious Diseases,Influenza,Treatment of the flu (influenza) in people twelve years of age and older ,2018,1119,yes,no,yes,no - white & asian majority,50,26,6,67,15,,0,,,34,Yes
XOSPATA,Astellas Pharma,Oncology,,Leukemia,Leukemia,Treatment of relapsed or refractory acute myeloid leukemia with one specific gene mutation ,2018,292,yes,no,yes,no - white & asian majority,53,62,5,24,5,,41,,,57,Yes
YUPELRI,Mylan,Pulmonology and Rheumatology,,COPD ,COPD ,Maintenance treatment of adults with a lung disease called COPD ,2018,813,yes,no,yes,no - white majority,51,90,9,1,4,,48,,,100,No. Dr. Bierer reviewed TA label
ZEMDRI,Achaogen,Infectious Disease,,Urinary tract infection,Urinary tract infection,Treatment of adults who have a complicated urinary tract infection ,2018,604,yes,no,yes,no - white majority,53,99,0,0,1,,46,,,1,Yes
ACCRUFER,Shield Therapeutics,Hematology,,Other Hematology,Iron deficiency ,Treatment of iron deficiency ,2019,295,yes,no,yes,no - white majority,68,83,12,2,14,,41,,,57,Yes
ADAKVEO,Novartis,Hematology,,Sickle Cell,Sickle Cell,Treatment of vasooclusive crisis in sickle cell disease ,2019,132,yes,no,no,no - black majority,55,5,91,,24,,0,,,75,Yes
AKLIEF,Galderma Laboratories,Dermatology,,Acne vulgaris,Acne vulgaris,Treatment of acne vulgaris ,2019,2420,yes,yes,yes,yes,55,87,7,3,17,,0,,,45,No. Dr. Bierer reviewed TA label
BALVERSA,Janssen,Oncology,,Bladder cancer,Bladder cancer,Treatment of urothelial carcinoma ,2019,87,yes,no,yes,no - white majority,21,74,2,5,2,,61,,,22,Yes
BEOVU,Novartis,Ophthalmology,,Ophthalmology,Wet age-related macular degeneration ,Treatment of wet age-related macular degeneration ,2019,1459,yes,no,yes,no - white & asian majority,56,86,1,11,8,,90,,,33,No. Dr. Bierer reviewed TA label
BRUKINSA,BeiGene,Oncology,,Lymphoma,Lymphoma,Treatment of mantle cell lymphoma ,2019,118,yes,no,yes,no - asian majority,25,21,1,76,,,39,,,8,Yes
CABLIVI,Ablynx,Hematology,,Other Hematology,Thrombotic thrombocytopenic purpura ,Treatment of an episode of acquired thrombotic thrombocytopenic purpura ,2019,216,yes,no,yes,no - white majority,67,74,17,2,3,,6,,,22,Yes
CAPLYTA,Intra-Cellular Therapies,Psychiatry,,Schizophrenia,Schizophrenia,Treatment of schizophrenia ,2019,818,yes,yes,yes,yes,24,21,75,1,9,,0,,,100,Yes
DAYVIGO,Eisai,Sleep Disorders,,Sleep Disorders,Insomnia,Treatment of insomnia ,2019,1692,yes,yes,yes,yes,76,73,15,11,12,,35,,,54,Yes
EGATEN,Novartis,Infectious Disease,,Other Infectious Diseases,Fascioliasis ,Treatment of fascioliasis ,2019,466,yes,no,yes,not collected,58,,,,,,4,,,0,No. Dr. Bierer reviewed TA label
ENHERTU,Daiichi Sankyo,Oncology,,Breast cancer,Breast cancer,Metastatic HER2-positive breast cancer ,2019,234,n/a - women,no,yes,no - white & asian majority,100,51,3,42,6,,26,,,35,Yes
EVENITY,Amgen,Gynecology,Changed from Pulmonology and Rheumatology,Gynecology,Osteoporosis in postmenopausal women ,Treatment of osteoporosis in postmenopausal women ,2019,11273,n/a - women,no,yes,no - white majority,100,62,2,10,37,,82,,,2,No. Dr. Bierer reviewed TA label
EXEM_FOAM,ExEm Foam Inc,Gynecology,,Gynecology,Detection of fallopian tubes patency,Detection of fallopian tubes patency in women with infertility ,2019,182,n/a - women,no,not collected,not collected,100,,,,,,,,,0,No. Dr. Bierer reviewed TA label
FETROJA,Shionogi,Infectious Disease,,Urinary tract infection,Urinary tract infection,Treatment of complicated urinary tract infection ,2019,448,yes,no,yes,no - white majority,55,96,,3,2,,53,,,2,No. Dr. Bierer reviewed TA label
FLUORODOPA_F_18,The Feinstein Institutes for Medical Research,Medical Imaging,,Medical Imaging,Detection of certain nerve cells in patients with Parkinsonian syndromes ,Detection of certain nerve cells in patients with Parkinsonian syndromes ,2019,56,yes,no,yes,not collected,32,,,,,,63,,,100,No. Dr. Bierer reviewed TA label
Ga_68_DOTATOC,UHC – PET Imaging Center,Medical Imaging,,Medical Imaging,Detection of somatostatin receptor positive neuroendocrine tumors ,Detection of somatostatin receptor positive neuroendocrine tumors ,2019,334,yes,no,yes,no - white majority,57,94,2,1,2,,18,,,100,No. Dr. Bierer reviewed TA label
GIVLAARI,Alnylam Pharmaceuticals,Hematology,,Other Hematology,Acute hepatic porphyria ,Treatment of acute hepatic porphyria ,2019,94,no,no,no,no - white majority,89,78,1,16,9,,1,,,34,Yes
IBSRELA,Ardelyx,Gastroenterology,,Gastroenterology,Irritable bowel syndrome,Treatment of irritable bowel syndrome with constipation ,2019,1199,yes,yes,yes,yes,82,64,31,3,28,,8,,,100,No. Dr. Bierer reviewed TA label
INREBIC,Celgene,Oncology,,Other oncology,Myelofibrosis ,Treatment of myelofibrosis ,2019,192,yes,yes,yes,yes,43,92,1,7,,,45,,,8,Yes
JEUVEAU,Evolus,Dermatology,,Other Dermatology,Temporary improvement of glabellar lines ,Temporary improvement of glabellar lines ,2019,654,no,no,no,no - white majority,91,84,8,2,0,,10,,,100,No. Dr. Bierer reviewed TA label
MAYZENT,Novartis,Neurology,,Multiple Sclerosis,Multiple Sclerosis,Treatment of relapsing forms of multiple sclerosis ,2019,1651,yes,no,yes,no - white majority,60,95,1,3,6,,0,,,9,Yes
NOURIANZ,Kyowa Kirin,Neurology,,Parkinson's,Parkinson's,Treatment of off episodes in patients with Parkinsons disease ,2019,1160,yes,no,yes,no,49,34,1,64,,,52,,,32,Yes
NUBEQA,Bayer,Oncology,,Prostate cancer,Prostate cancer,Treatment of prostate cancer ,2019,1509,n/a - men,no,yes,no - white & asian majority,0,79,3,13,3,,87,,,9,Yes
OXBRYTA,Global Blood Therapeutics,Hematology,,Sickle Cell,Sickle Cell,Treatment of sickle cell disease ,2019,182,yes,no,no,no - black majority,59,24,67,1,3,,0,,,36,Yes
PADCEV,Astellas Pharma,Oncology,,Bladder cancer,Bladder cancer,Treatment of urothelial carcinoma ,2019,125,yes,no,yes,no - white majority,30,85,2,9,4,,64,,,94,Yes
PIQRAY,Novartis,Oncology,,Breast cancer,Breast cancer,Treatment of advanced breast cancer ,2019,571,n/a - women,no,yes,no - white majority,100,66,1,22,14,,44,,,9,Yes
POLIVY,Genentech,Oncology,,Lymphoma,Lymphoma,Treatment of diffuse large B- cell lymphoma ,2019,80,no,no,no,no,34,71,4,12,3,,61,,,30,Yes
PRETOMANID,Mylan,Infectious Disease,,Other Infectious Diseases,Lung tuberculosis ,Treatment of lung tuberculosis ,2019,109,yes,no,yes,no - black majority,48,1,76,,,,0,,,0,No. Dr. Bierer reviewed TA label
REBLOZYL,Celgene,Hematology,,Other Hematology,Anemia,Treatment of anemia in patients with beta thalassemia ,2019,336,yes,yes,yes,yes,58,54,1,35,2,,0,,,8,Yes
RECARBRIO,Merck,Infectious Disease,,Urinary tract infection,Urinary tract infection,Treatment of complicated urinary infection ,2019,430,yes,no,yes,no - white majority,43,92,1,3,6,,30,,,4,No. Dr. Bierer reviewed TA label
REYVOW,Eli Lilly,Neurology,,Migraine,Migraine,Treatment of acute migraine ,2019,4439,yes,yes,yes,yes,84,78,18,1,18,,4,,,90,Yes
RINVOQ,AbbVie,Pulmonology and Rheumatology,,Rheumatoid arthritis ,Rheumatoid arthritis ,Treatment of rheumatoid arthritis ,2019,3141,yes,yes,yes,yes,79,85,6,7,27,,20,,,26,No. Dr. Bierer reviewed TA label
ROZLYTREK,Genentech,Oncology,,NSCLC,NSCLC,Treatment of non-small cell lung cancer ,2019,355,yes,no,no,no - white & asian majority,55,66,5,23,3,,25,,,51,Yes
SCENESSE,Clinuvel,Hematology,,Other Hematology,Erythropoietic protoporphyria,Increasing pain-free light exposure in patients with EPP ,2019,244,yes,no,no,no - white majority,47,98,0,1,,,4,,,70,No. Dr. Bierer reviewed TA label
SKYRIZI,AbbVie,Dermatology,,Plaque psoriasis,Plaque psoriasis,Treatment of plaque psoriasis ,2019,1606,yes,no,yes,no - white majority,30,78,3,17,11,,11,,,40,No. Dr. Bierer reviewed TA label
SUNOSI,Jazz Pharmaceuticals,Sleep Disorders,,Sleep Disorders,Narcolepsy or obstructive sleep apnea,Improvement of wakefulness in patients with narcolepsy or obstructive sleep apnea ,2019,622,yes,no,yes,no - white majority,49,77,18,2,8,,12,,,90,Yes
TISSUEBLUE,Dutch Ophthalmic,Ophthalmology,Medical Imaging,Ophthalmology,Staining the internal limiting membrane,Staining the internal limiting membrane,2019,96,no,no,no,no,63,,,,,,,,,,No. Dr. Bierer reviewed TA label
TRIKAFTA,Vertex,Pulmonology and Rheumatology,,Cystic fibrosis,Cystic fibrosis,Treatment of cystic fibrosis ,2019,510,yes,no,yes,no - black majority,50,93,1,,4,,0,,,60,No. Dr. Bierer reviewed TA label
TURALIO,Daiichi Sankyo,Oncology,,Other oncology,Tenosynovial giant cell tumor ,Treatment of tenosynovial giant cell tumor ,2019,120,yes,no,no,no - white majority,59,88,3,3,14,,6,,,38,Yes
UBRELVY,Allergan,Neurology,,Migraine,Migraine,Treatment of acute migraine ,2019,2423,yes,yes,yes,yes,89,82,15,1,15,,3,,,100,Yes
VYLEESI,AMAG Pharmaceuticals,Gynecology,,Gynecology,Hypoactive sexual desire disorder ,Treatment of women with hypoactive sexual desire disorder ,2019,1267,yes,no,yes,no - white majority,100,86,12,1,9,,0,,,97,No. Dr. Bierer reviewed TA label
VYNDAQEL/VYNDAMAX,Pfizer,Cardiovascular Diseases,,Cardiomyopathy,Cardiomyopathy,Treatment of certain type of cardiomyopathy ,2019,441,yes,yes,yes,yes,10,81,14,,3,,91,,,63,No. Dr. Bierer reviewed TA label
VYONDYS_53,Serepta,Neurology,,Muscular dystrophy,Muscular dystrophy,Treatment of Duchenne muscular dystrophy ,2019,62,no,no,no,no - white majority,0,86,2,6,16,,0,,,81,Yes
WAKIX,Harmony Bioscience,Sleep Disorders,,Sleep Disorders,Narcolepsy,Treatment of excessive daytime sleepiness in patients with narcolepsy ,2019,266,yes,no,no,no - white majority,50,55,2,,,,6,,,0,Yes
XCOPRI,"SK Life Science, Inc.",Neurology,,Seizures,Seizures,Treatment of partial-onset seizures ,2019,655,yes,no,no,no - white majority,49,74,3,21,7,,2,,,29,Yes
XENLETA,"NABRIVA Therapeutics, Inc.",Infectious Disease,,Other Infectious Diseases,Bacterial pneumonia ,Treatment of community-acquired bacterial pneumonia ,2019,1289,yes,no,yes,no - white & asian majority,44,79,5,11,8,,40,,,2,No. Dr. Bierer reviewed TA label
XPOVIO,Karyopharm Therapeutics Inc.,Oncology,,Multiple Myeloma,Multiple Myeloma,Treatment of multiple myeloma ,2019,202,yes,no,yes,no - white majority,47,73,17,1,5,,48,,,81,Yes
ZULRESSO,"Sage Therapeutics, Inc.",Psychiatry,,Postpartum depression,Postpartum depression,Treatment of postpartum depression ,2019,247,n/a - women,yes,yes,yes,100,61,36,1,17,,0,,,100,Yes
ARTESUNATE,Amivas,Infectious Disease,,Other Infectious Diseases,Malaria,Treatment of malaria,2020,1461,,,,,26,,,,,,3,,,0,Yes
AYVAKIT,Blueprint Medicines Corporation,Oncology,,Other oncology,Gastrointestinal stromal tumors,Treatment of gastrointestinal stromal tumors,2020,204,,,,,39,72,4,10,3,,40,,,45,Yes
BARHEMSYS,Acacia Pharma,Anesthesia and Analgesia,,Anesthesia and Analgesia,Post-operative nausea and vomiting,Treatment of post-operative nausea and vomiting,2020,2323,,,,,88,79,9,1,10,,14,,,63,No. Dr. Bierer reviewed TA label
BLENREP,GlaxoSmithKline,Oncology,,Multiple Myeloma,Multiple Myeloma,Treatment of multiple myeloma,2020,97,,,,,47,78,16,2,4,,53,,,61,Yes
BYFAVO,Acacia Pharma,Anesthesia and Analgesia,,Anesthesia and Analgesia,Sedation for short procedures,Sedation for short procedures,2020,966,,,,,52,78,17,4,8,,31,,,100,No. Dr. Bierer reviewed TA label
CERIANNA,Zionexa,Oncology,,Breast cancer,Breast cancer,Detection of estrogen positive lesions in breast cancer,2020,109,,,,,100,15,2,83,0,,,,,17,No. Dr. Bierer reviewed TA label
DANYELZA,Y-mAbs Therapeutics,Oncology,,Other oncology,Neuroblastoma,Treatment of neuroblastoma,2020,97,,,,,37,69,3,18,6,,0,,,84,Yes
DETECTNET,RadioMedix,Oncology,,Other oncology,Neuro-endocrine tumors,Detection of certain neuro-endocrine tumors,2020,175,,,,,48,31,3,1,6,,38,,,36,No. Dr. Bierer reviewed TA label
DOJOLVI,Ultragenyx Pharmaceutical,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Fatty acid oxidation disorder,Source of calories for fatty acid oxidation disorder,2020,265,,,,,52,87,5,4,9,,0,,,91,No. Dr. Bierer reviewed TA label
EBANGA,Ridgeback Biotherapeutics,Infectious Disease,,Other Infectious Diseases,Ebola,Treatment of Ebola infection,2020,342,,,,,54,0,0,0,0,,3,,,0,Yes
ENSPRYNG,Genentech,Neurology,,Other Neurology,Neuromyelitis optica spectrum disorder,Treatment of neuromyelitis optica spectrum disorder,2020,116,,,,,91,48,12,35,9,,,,,29,No. Dr. Bierer reviewed TA label
EVRYSDI,Genentech,Neurology,,Other Neurology,Spinal muscular atrophy,Treatment of spinal muscular atrophy,2020,201,,,,,53,69,1,19,3,,0,,,3,Yes
Ga 68 PSMA-11,"UCLA Nuclear Medicine, UCSF Nuclear Medicine",Medical Imaging,,Medical Imaging,Detection of specific cancer lesions in men with prostate cancer,Detection of specific cancer lesions in men with prostate cancer,2020,960,,,,,0,85,2,4,4,,72,,,100,No. Dr. Bierer reviewed TA label
GAVRETO,Blueprint Medicines Corporation,Oncology,,NSCLC,NSCLC,Treatment of non-small cell lung cancer,2020,220,,,,,52,50,0,41,4,,37,,,26,Yes
GEMTESA,Urovant Sciences,Gynecology,,Urology,Overactive bladder,Treatment of symptoms of overactive bladder,2020,1085,,,,,85,79,15,5,73,,44,,,90,No. Dr. Bierer reviewed TA label
IMCIVREE,RHYTHM Pharmaceuticals,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Obesity,Treatment of obesity in patients with certain rare disorder,2020,27,,,,,52,67,0,4,7,,0,,,4,No. Dr. Bierer reviewed TA label
INMAZEB,Regeneron,Infectious Disease,,Other Infectious Diseases,Ebola,Treatment of Ebola infection,2020,322,,,,,55,,,,,,,,,0,Yes
INQOVI,Taiho Oncology,Oncology,,Other oncology,Myelodyspastic syndromes,Treatment of myelodyspastic syndromes,2020,213,,,,,31,92,3,2,5,,75,,,82,Yes
ISTURISA,Novartis,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Cushing's disease,Treatment of Cushing's disease,2020,137,,,,,77,65,3,29,9,,5,,,18,No. Dr. Bierer reviewed TA label
KLISYRI,Almirall,Dermatology,,Other Dermatology,Actinic keratosis,Treatment of actinic keratosis,2020,702,,,,,13,100,0,0,4,,73,,,100,No. Dr. Bierer reviewed TA label
KOSELUGO,AstraZeneca,Oncology,,Other oncology,Neurofibroma,Treatment of neurofibroma,2020,50,,,,,40,84,8,2,4,,0,,,100,Yes
LAMPIT,Bayer,Infectious Disease,,Other Infectious Diseases,Chagas disease,Treatment of Chagas disease,2020,219,,,,,54,71,0,0,99,,0,,,0,Yes
MARGENZA,MacroGenics,Oncology,,Breast cancer,Breast cancer,Treatment of metastatic HER2-positive breast cancer,2020,536,,,,,99,80,5,6,9,,21,,,33,Yes
MONJUVI,MorphoSys,Oncology,,Lymphoma,Lymphoma,Treatment of diffuse large b-cell lymphoma,2020,81,,,,,46,89,0,3,,,69,,,7,Yes
NEXLETOL,Esperion,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,High LDL cholesterol,Treatment of high LDL cholesterol,2020,3009,,,,,29,96,3,1,3,,58,,,26,No. Dr. Bierer reviewed TA label
NURTEC,Biohaven Pharmaceutical,Neurology,,Migraine,Migraine,Treatment of acute migraine,2020,1351,,,,,85,75,20,2,19,,2,,,100,Yes
OLINVYK,Trevena,Anesthesia and Analgesia,,Anesthesia and Analgesia,Acute pain,Treatment of acute pain,2020,1558,,,,,79,72,23,2,19,,18,,,100,No. Dr. Bierer reviewed TA label
ONGENTYS,Neurocrine Biosciences,Neurology,,Parkinson's,Parkinson's,"Treatment of ""off episodes"" in Parkinson's disease",2020,522,,,,,42,85,0,14,,,48,,,0,Yes
ORGOVYX,Myovant Sciences,Oncology,,Prostate cancer,Prostate cancer,Treatment of prostate cancer,2020,930,,,,,0,68,5,21,9,,81,,,24,Yes
ORLADEYO,BioCryst Pharmaceuticals,Dermatology,,Other Dermatology,Hereditary angioedema,Prevention of hereditary angioedema attacks,2020,120,,,,,66,94,3,1,3,,8,,,63,No. Dr. Bierer reviewed TA label
OXLUMO,Alnylam Pharmaceuticals,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Primary hyperoxaluria type 1,Treatment of primary hyperoxaluria type 1,2020,55,,,,,40,80,0,11,4,,0,,,25,No. Dr. Bierer reviewed TA label
PEMAZYRE,Incyte,Oncology,,Other oncology,Bile duct cancer,Treatment of metastatic bile duct cancer,2020,146,,,,,57,71,6,15,4,,31,,,61,Yes
PIZENSY,Braintree Laboratories,Gastroenterology,,Gastroenterology,Chronic idiopathic constipation,Treatment of chronic idiopathic constipation,2020,594,,,,,76,60,31,7,38,,27,,,100,No. Dr. Bierer reviewed TA label
QINLOCK,Deciphera Pharmaceuticals,Oncology,,Other oncology,Gastrointestinal stromal tumors,Treatment of gastrointestinal stromal tumors,2020,129,,,,,43,75,8,7,1,,39,,,47,Yes
RETEVMO,Eli Lilly,Oncology,,Other oncology,Cancers caused by specific genes,Treatment of certain cancers caused by specific genes,2020,702,,,,,48,69,3,22,5,,34,,,61,Yes
RUKOBIA,ViiV Healthcare,Infectious Disease,,HIV-1,HIV-1,Treatment of HIV-1 infection,2020,272,,,,,26,68,22,1,29,,4,,,32,Yes
SARCLISA,Sanofi,Oncology,,Multiple Myeloma,Multiple Myeloma,Treatment of multiple myeloma,2020,307,,,,,48,80,1,12,2,,60,,,2,Yes
SOGROYA,Novo Nordisk,Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Replacement of growth hormone,Replacement of growth hormone,2020,300,,,,,52,67,2,29,6,,14,,,26,No. Dr. Bierer reviewed TA label
TABRECTA,Novartis,Oncology,,NSCLC,NSCLC,Treatment of non-small cell lung cancer,2020,334,,,,,41,74,1,24,7,,57,,,10,Yes
TAUVID,Eli Lilly,Neurology,,Other Neurology,Alzheimer's disease,Detection of aggregated neurofibrillary tangles in Alzheimer's disease,2020,1921,,,,,50,86,5,6,5,,80,,,77,No. Dr. Bierer reviewed TA label
TAZVERIK,Epizyme,Oncology,,Other oncology,Advanced epithelioid sarcoma,Treatment of advanced epithelioid sarcoma,2020,62,,,,,37,76,7,11,11,,3,,,65,Yes
TEPEZZA,Horizon,Ophthalmology,,Ophthalmology,Thyroid eye disease,Treatment of thyroid eye disease,2020,170,,,,,73,87,8,4,5,,15,,,57,No. Dr. Bierer reviewed TA label
TRODELVY,Immunomedics,Oncology,,Breast cancer,Breast cancer,Treatment of breast cancer,2020,108,,,,,99,76,7,3,7,,18,,,100,Yes
TUKYSA,Seattle Genetics,Oncology,,Breast cancer,Breast cancer,Treatment of breast cancer,2020,601,,,,,99,73,9,4,8,,19,,,54,Yes
UPLIZNA,Viela Bio,Neurology,,Other Neurology,Neuromyelitis optica spectrum disorder,Treatment of neuromyelitis optica spectrum disorder,2020,213,,,,,94,52,9,21,19,,5,,,18,No. Dr. Bierer reviewed TA label
VEKLURY,Gilead,Infectious Disease,,Other Infectious Diseases,COVID-19,Treatment of COVID-19,2020,2043,,,,,37,57,18,14,21,,35,,,65,Yes
VILTEPSO,NS Pharma,Neurology,,Muscular dystrophy,Muscular dystrophy,Treatment of Duchenne muscular dystrophy,2020,16,,,,,0,44,0,56,6,,0,,,38,Yes
VYEPTI,Lundbeck,Neurology,,Migraine,Migraine,Treatment of migraine,2020,1741,,,,,87,88,9,1,12,,1,,,68,Yes
WINLEVI,Cassiopea SpA,Dermatology,,Acne vulgaris,Acne vulgaris,Treatment of acne vulgaris,2020,1440,,,,,63,90,6,2,14,,0,,,41,No. Dr. Bierer reviewed TA label
XEGLYZE,Dr. Reddy’s Laboratories,Dermatology,,Other Dermatology,Head lice,Treatment of head lice,2020,699,,,,,84,97,1,0,66,,0,,,100,No. Dr. Bierer reviewed TA label
ZEPOSIA,Celgene,Neurology,,Multiple Sclerosis,Multiple Sclerosis,Treatment of multiple sclerosis,2020,1767,,,,,67,99,1,0,1,,0,,,3,Yes
ZEPZELCA,"Pharma Mar, S.A.",Oncology,,Other oncology,Small cell lung cancer,Treatment of small cell lung cancer,2020,105,,,,,40,75,1,1,,,35,,,10,Yes
ZOKINVY,"Eiger BioPharmaceuticals, Inc.",Endocrinology and Metabolism,,Other Endocrinology and Metabolism,Premature aging,Treatment of rare conditions related to premature aging,2020,63,,,,,48,,,,,,0,,,19,No. Dr. Bierer reviewed TA label